KOZARICH JOHN W sold 1.1% of their position (467.00 shares) of LIGAND PHARMACEUTICALS INC on the open market
Open‑market sale worth $94.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 5 sales
Filed: 4/2/2026ACC: 0002001011-26-000038
-467.00
Net shares
Net seller
$94.4K
Total sold
5
Open market trades
0B · 5S
5
Total transactions
467.00 disposed
Non-Derivative Transactions5
Common Stock
Direct
Shares
−146.00
Price / share
$199.97
Trade value
$29.20K
% of position
0.3%
4/1/2026
42.72K→42.57K
Common Stock
Direct
Shares
−40.00
Price / share
$201.24
Trade value
$8.05K
% of position
0.1%
4/1/2026
42.57K→42.53K
Common Stock
Direct
Shares
−79.00
Price / share
$202.42
Trade value
$15.99K
% of position
0.2%
4/1/2026
42.53K→42.45K
Common Stock
Direct
Shares
−43.00
Price / share
$202.91
Trade value
$8.73K
% of position
0.1%
4/1/2026
42.45K→42.41K
Common Stock
Direct
Shares
−159.00
Price / share
$204.26
Trade value
$32.48K
% of position
0.4%
4/1/2026
42.41K→42.25K
Total
Net shares
−467.00
Net value
-$94.44K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2026 | S · Sale | −146.00 | $199.97 | $29.20K | 0.3% | 42.72K | 42.57K |
| Common Stock Direct | 4/1/2026 | S · Sale | −40.00 | $201.24 | $8.05K | 0.1% | 42.57K | 42.53K |
| Common Stock Direct | 4/1/2026 | S · Sale | −79.00 | $202.42 | $15.99K | 0.2% | 42.53K | 42.45K |
| Common Stock Direct | 4/1/2026 | S · Sale | −43.00 | $202.91 | $8.73K | 0.1% | 42.45K | 42.41K |
| Common Stock Direct | 4/1/2026 | S · Sale | −159.00 | $204.26 | $32.48K | 0.4% | 42.41K | 42.25K |
| Total | −467.00 | -$94.44K | ||||||
Derivative Transactions0
No derivative transactions reported